Development Assistance for COVID-19 Vaccine Delivery 2020-2021
GHDx Entry last modified on: Mar 16, 2023
COVID-19
Dataset Records for COVID-19
Displaying 1201 - 1250 of 1622
Development Assistance for COVID-19 Vaccine Delivery 2020-2021
The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy
GHDx Entry last modified on: Mar 22, 2024
Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge
GHDx Entry last modified on: Mar 22, 2024
Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort
GHDx Entry last modified on: Mar 22, 2024
Humoral Immune Response to SARS-CoV-2 in Iceland
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Scientific literature:
Cross-sectional
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study. Preprint
GHDx Entry last modified on: Mar 14, 2022
New onset neurologic events in people with COVID-19 in 3 regions in China
GHDx Entry last modified on: Jan 31, 2024
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
GHDx Entry last modified on: Mar 14, 2022
Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants
GHDx Entry last modified on: Jan 31, 2024
Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Long-term COVID-19 symptoms in a large unselected population. Preprint
GHDx Entry last modified on: Apr 10, 2023
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
GHDx Entry last modified on: Jan 31, 2024
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
GHDx Entry last modified on: Mar 14, 2022
New Zealand Monthly Notifiable Disease Surveillance Report, January 2021
Epi surveillance:
Subnationally representative
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
A Single-centre Study of COVID-19 Antibody
GHDx Entry last modified on: Mar 14, 2022
Low seroprevalence of COVID-19 in Lao PDR, late 2020
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
GHDx Entry last modified on: Mar 14, 2022
Armenia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee
GHDx Entry last modified on: Jan 31, 2024
Logistics Workers Are a Key Factor for SARS-CoV-2 Spread in Brazilian Small Towns: Case-Control Study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Post COVID-19 sequelae: A prospective observational study from Northern India
GHDx Entry last modified on: Jan 31, 2024
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York
GHDx Entry last modified on: Jan 31, 2024
Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13062 positive pregnancies including 176 maternal deaths in Mexico
GHDx Entry last modified on: Apr 10, 2023
Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis
GHDx Entry last modified on: Apr 10, 2023
Prevalence and Neighborhood Geomapping of COVID-19 in an Underserved Chicago Pregnant Population
GHDx Entry last modified on: Apr 10, 2023
Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study
GHDx Entry last modified on: Dec 12, 2023
Iraq Annual Statistical Report 2020
التقرير االحصائي السنوي
Report:
Epi surveillance - Inpatient - National vital registration - Nationally representative - Outpatient - Subnationally representative
Rationale, Design, and Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
GHDx Entry last modified on: Mar 22, 2024
Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA)
GHDx Entry last modified on: Mar 22, 2024
Risk factors associated with limited functional status among out-of-hospital patients 30days and one year after a diagnosis of COVID-19: a cohort study
GHDx Entry last modified on: Mar 22, 2024
Symptom Burden among Older COVID-19 Survivors Two Years after Hospital Discharge
GHDx Entry last modified on: Mar 22, 2024
Sri Lanka Epidemiology Unit Coronavirus Disease 2019 (COVID-19) Situation Report 2020-2022
Coronavirus disease 2019 (COVID-19) - Situation Report
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
GHDx Entry last modified on: Mar 14, 2022
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. Preprint
Scientific literature:
Household
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Subscribe